RE: Results22 Sep 2015 12:17
of course sub £6 is possible.
equity = risk, all of our
shares could just plummet.
that's the name of the game.
yes, you predicted sub £6
repeatedly, and kept saying
it would happen soon. nope.
even the 'great fall of china'
couldn't push it to that levels,
& it recovered v. nicely after,
making me money in process.
the market has not been agreeing
with you about clinigen rylidan.
you've claimed it's been ramped
up and overvalued, but one year
graph tells the story very nicely
about the development of this
company. clinigen currently down
just over 2%, main market down
circa 2.5%, i'm happy with that.
this share is not immune from
wider moves on general markets,
& will have ups & downs, of course.
results seem to have been accepted
pretty happily by the market after the
analyst conference. no major surprises,
but no big quibbles either. a proper
company doing proper business with
a visible and transparent business plan
that involves earning honest money.
different from many companies on aim.
(& note that today's acquisition is again
an earnings enhancing one from outset.)
.... it will be interested to see what revised
analyst forecasts may be. i don't expect
any stellar / step changes, but a few
updates would be nice, and about time.